NEW YORK (GenomeWeb) – Shares of Genomic Health and Pacific Biosciences jumped significantly in November to lead a surge in stock prices for many firms in the omics tools and molecular diagnostics industries.

Overall, the GenomeWeb Index, which tracks the share prices of 31 tools and MDx firms, jumped nearly 7 percent in the month of November. The index far outpaced the performance of the Dow Jones Industrial Average (up .3 percent), the Nasdaq (up 1 percent), and the Nasdaq Biotech Index (up nearly 3 percent).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.